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Purpose of the study
Globally, the incidence of HIV-associated tuberculosis
(TB) infection is increasing. In this regard TB-associated
immune reconstitution inflammatory syndrome (IRIS)
after initiation of antiretroviral therapy is well recognised
with rates as high as 45% being reported. The aim of this
study was to review the clinical presentation of patients
with TB/HIV co-infection and the incidence of IRIS in a
large academic medical centre in Dublin.
Methods
A retrospective chart review was conducted on HIV-posi-
tive patients diagnosed with TB between December 2003
and May 2008. All patients were HIV positive and had a
confirmed mycobacterial tuberculosis diagnosis, or a clin-
ically presumptive diagnosis with response to anti-tuber-
culosis therapy. Data collected included patient
demographics, clinical presentation, baseline CD4 counts
and the development of a clinical syndrome consistent
with IRIS.
Summary of results
Of the 30 charts reviewed, 18 (60%) were female and 12
(40%) were male. Seven patients (23%) were European
(six Irish and one British) while the remainder of the
patients were from sub-Saharan Africa or south-east Asia.
Thirteen (43%) had pulmonary disease, the remainder
(17 patients) presented with extra-pulmonary disease and
of these, eight (27%) had disseminated disease. Five
(17%) presented with lymphadenitis, three (10%) with
cerebral TB or meningitis and one (3%) patient with peri-
toneal tuberculosis. One patient had multi-drug resistant
tuberculosis and another had streptomycin resistance. At
the time of their TB diagnosis, 18 (60%) had a CD4 count
of less than 200 and 22 (73%) were antiretroviral therapy
(ART) naïve. Eleven (37%) had a baseline HIV viral load
greater than 100,000 copies/ml. Four (13%) patients had
a clinical syndrome consistent with IRIS following initia-
tion of their anti-TB therapy, all of whom had a CD4
count less than 100. Three of the patients presented with
high grade temperatures and one presented with worsen-
ing lymphadenopathy. ART was initiated at a median
duration of 8 weeks after TB treatment; one patient did
not receive ART during their TB therapy. Two patients had
disseminated disease, one extra-pulmonary disease and
one pulmonary disease.
Conclusion
HIV/TB co-infection is more prevalent in the immigrant
population. Our rate of IRIS is 13% in patients co-infected
with HIV/TB, which is lower than previous series. The
development of IRIS depends on the population studied,
but extrapulmonary tuberculosis and low CD4 counts
appear to be risk factors for IRIS.
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